Luis Enjuanes

Hospital Sant Joan de Déu Barcelona — Spain

Agricultural and Biological Sciences · Life Sciences

82h-index23.0kcitations320works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Animal Virus Infections Studies(196), Viral gastroenteritis research and epidemiology(188), SARS-CoV-2 and COVID-19 Research(145), Virus-based gene therapy research(71), Viral Infections and Immunology Research(37)

Publications320 total

Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor
Molecular Aspects of Medicine·2025
SARS-CoV-2-derived RNA replicons as safe and effective vaccines
Proceedings of the National Academy of Sciences·2025Open Access
SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues
Journal of Virology·2025· 1 citedOpen Access
Generation and Characterization of <i>Col6a1</i> knock-in mice: A Promising Pre-Clinical Model for Collagen VI-Related Dystrophies
2025· 2 citedOpen Access
Biocompatible Iron Oxide Nanoparticles Display Antiviral Activity Against Two Different Respiratory Viruses in Mice
International Journal of Nanomedicine·2024· 2 citedOpen Access
Interaction between SARS-CoV PBM and Cellular PDZ Domains Leading to Virus Virulence
Viruses·2024· 2 citedOpen Access
Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell culture
British Journal of Pharmacology·2024· 16 citedOpen Access
Correction for Castaño-Rodriguez et al., “Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis”
mBio·2023· 1 citedOpen Access
Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis
Frontiers in Cellular and Infection Microbiology·2023· 9 citedOpen Access
SARS-CoV-2 ORF8 accessory protein is a virulence factor
mBio·2023· 19 citedOpen Access
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice
Proceedings of the National Academy of Sciences·2023· 58 citedOpen Access
Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo
Frontiers in Microbiology·2023· 13 citedOpen Access
Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
Frontiers in Cellular and Infection Microbiology·2023· 13 citedOpen Access
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice
2023· 11 citedOpen Access
Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
Viruses·2023· 13 citedOpen Access
Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase
Nature Communications·2023· 13 citedOpen Access
SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators
mBio·2023· 24 citedOpen Access
Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin
Antimicrobial Agents and Chemotherapy·2023· 10 citedOpen Access
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
Figshare·2023Open Access
Cytoplasmic ribonucleoprotein complexes, RNA helicases and coronavirus infection
Frontiers in Virology·2022Open Access
page 1 of 16Next →

Frequent Co-authors

Isabel Sola(16), Marta L. DeDiego(16), Sonia Zúñiga(12), José L. Nieto-Torres(12), Stanley Perlman(10), Jose M. Jiménez-Guardeño(10), José Ángel Regla-Nava(10), Carlos Castaño-Rodríguez(10), Fernando Almazán(9), Raúl Fernández‐Delgado(9), Enrique Alarcón Álvarez(5), Alexander E. Gorbalenya(4), Carmina Verdiá-Báguena(4), Vicente M. Aguilella(4), Craig Fett(4), Carlos M. Sánchez(4), Jaume Torres(3), Juan Plana-Durán(3), Francisco J. Gutierrez-Alvarez(3), David Escors(3)